Insulin Market Forecast to 2015
In the global biopharmaceutical industry, protein-based therapies are effectively being used to treat metabolic disorders, and autoimmune diseases. According to our new research report, the global market for insulin products is progressing on the strong growth trajectory as the number of people suffering from diabetes is increasing at a rapid rate worldwide. It is estimated that the market will advance at a CAGR of around 10% during 2012-2015.
The report, “Insulin Market Forecast to 2015”, says that new innovations in delivery devices are also likely to fuel growth in the global insulin market. In the recent years, many alternatives to insulin syringes have been launched, including pen devices, and insulin pumps. Our comprehensive research work also studies how government initiatives are stimulating the growth, and what are the challenges that the overall market may face in near future.
Our extensive study looks into the competitive landscape and finds that Novo Nordisk is the top player in the global insulin market, followed by Sanofi-Aventis and Eli Lilly. The report includes an overview of the activities of these companies. It also studies key geographies, such as BRIC nations and the United States to understand the structure of the insulin market in these countries. Overall, the research aims at presenting a balanced picture of the global insulin market to clients.
The report, “Insulin Market Forecast to 2015”, says that new innovations in delivery devices are also likely to fuel growth in the global insulin market. In the recent years, many alternatives to insulin syringes have been launched, including pen devices, and insulin pumps. Our comprehensive research work also studies how government initiatives are stimulating the growth, and what are the challenges that the overall market may face in near future.
Our extensive study looks into the competitive landscape and finds that Novo Nordisk is the top player in the global insulin market, followed by Sanofi-Aventis and Eli Lilly. The report includes an overview of the activities of these companies. It also studies key geographies, such as BRIC nations and the United States to understand the structure of the insulin market in these countries. Overall, the research aims at presenting a balanced picture of the global insulin market to clients.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. GLOBAL PROTEIN THERAPEUTICS MARKET
3.1 Protein Therapeutics Market Vs Pharmaceutical Market
3.2 Current and Future Market Analysis to 2015
3.2.1 Market Segmentation
4. INSULIN MARKET FORECAST TO 2015
4.1 Scientific Insight
4.2 Current and Future Market Analysis to 2015
4.3 By Application
4.4 Key Geographical Markets
4.5 Key Players and Drugs
4.6 Recent Developments
5. KEY PLAYERS
5.1 Sanofi-Aventis
5.2 Novo Nordisk
5.3 Eli Lilly & Company
2. RESEARCH METHODOLOGY
3. GLOBAL PROTEIN THERAPEUTICS MARKET
3.1 Protein Therapeutics Market Vs Pharmaceutical Market
3.2 Current and Future Market Analysis to 2015
3.2.1 Market Segmentation
4. INSULIN MARKET FORECAST TO 2015
4.1 Scientific Insight
4.2 Current and Future Market Analysis to 2015
4.3 By Application
4.4 Key Geographical Markets
4.5 Key Players and Drugs
4.6 Recent Developments
5. KEY PLAYERS
5.1 Sanofi-Aventis
5.2 Novo Nordisk
5.3 Eli Lilly & Company
LIST OF FIGURES
Figure 3-1: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2011
Figure 3-2: Global - Protein Therapeutics Market (Billion US$), 2011-2015
Figure 3-3: Global - Protein Therapeutics Market by Segment (%), 2011
Figure 3-4: Global - Forecast for Protein Therapeutics Market by Segment (%), 2015
Figure 4-1: Global - Insulin Market (Billion US$), 2011-2015
Figure 4-2: Global - Number of Diabetic Patients (Million), 2011 & 2030
Figure 4-3: India - Insulin Market (Million US$), 2011-2015
Figure 4-4: China - Insulin Market (Billion US$), 2011-2015
Figure 4-5: US - Insulin Market (Billion US$), 2011-2015
Figure 4-6: Russia - Insulin Market (Million US$), 2011-2015
Figure 4-7: Japan - Insulin Market (Billion US$), 2011-2015
Figure 4-8: Brazil - Insulin Market (Million US$), 2011-2015
Figure 4-9: Global - Share of Key Players in Insulin Market (2011)
Figure 4-10: Global - Share of Products in Insulin Market (2011)
Figure 3-1: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2011
Figure 3-2: Global - Protein Therapeutics Market (Billion US$), 2011-2015
Figure 3-3: Global - Protein Therapeutics Market by Segment (%), 2011
Figure 3-4: Global - Forecast for Protein Therapeutics Market by Segment (%), 2015
Figure 4-1: Global - Insulin Market (Billion US$), 2011-2015
Figure 4-2: Global - Number of Diabetic Patients (Million), 2011 & 2030
Figure 4-3: India - Insulin Market (Million US$), 2011-2015
Figure 4-4: China - Insulin Market (Billion US$), 2011-2015
Figure 4-5: US - Insulin Market (Billion US$), 2011-2015
Figure 4-6: Russia - Insulin Market (Million US$), 2011-2015
Figure 4-7: Japan - Insulin Market (Billion US$), 2011-2015
Figure 4-8: Brazil - Insulin Market (Million US$), 2011-2015
Figure 4-9: Global - Share of Key Players in Insulin Market (2011)
Figure 4-10: Global - Share of Products in Insulin Market (2011)
LIST OF TABLES
Table 4-1: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2011 & 2030
Table 4-2: China - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-3: US - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-4: Russia - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-5: Japan - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-6: Brazil - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 5-1: Sanofi-Aventis - Key Products in Protein Therapeutics
Table 5-2: Novo Nordisk - Key Products in Protein Therapeutics
Table 5-3: Eli Lilly - Key Products in Protein Therapeutics
Table 4-1: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2011 & 2030
Table 4-2: China - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-3: US - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-4: Russia - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-5: Japan - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 4-6: Brazil - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
Table 5-1: Sanofi-Aventis - Key Products in Protein Therapeutics
Table 5-2: Novo Nordisk - Key Products in Protein Therapeutics
Table 5-3: Eli Lilly - Key Products in Protein Therapeutics
